We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

NanoAssemblr™ Chosen for Horizon 2020 Project to Develop Novel RNA therapeutics

Product News   Mar 29, 2017 | Original story from Precision Nanosystems

 
NanoAssemblr™ Chosen for Horizon 2020 Project to Develop Novel RNA therapeutics

Credit: Precision NanoSystems

FURTHER INFORMATION
 
 
 

Related Product News

Smart Bioprocessing With New Bioreactor Control System

Product News

Eppendorf has introduced its latest bioreactor control system for small- and bench-scale applications.

READ MORE

The Native Antigen Company Introduces Novel Coronavirus Antigens

Product News

The Native Antigen Company has announced the commercial introduction of its Novel Coronavirus antigens, derived from the emerging Wuhan strain.

READ MORE

The Native Antigen Company Introduces Antigen and Antibody Conjugation Kits

Product News

The Native Antigen Company has announced the commercial release of its liquid format conjugation kits.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE